126 related articles for article (PubMed ID: 27313146)
1. Synthesis of N-(2-diethylamino-ethyl)-4-(4-fluoro-benzamido)-2-methoxybenzamide (desiodo-MIP-1145) by coupling technique and its radioiodination: a potential melanoma imaging agent.
Aglan H; Kandil SA; El-Kafrawy AF; Seddik U
J Labelled Comp Radiopharm; 2016 Jul; 59(9):372-4. PubMed ID: 27313146
[TBL] [Abstract][Full Text] [Related]
2. Direct electrophilic iodination of 2-thiouracil using Iodo-Gen.
Coderre JA; Halle DA
Int J Rad Appl Instrum A; 1989; 40(9):759-63. PubMed ID: 2559065
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
Baldwin RM; Fu X; Kula NS; Baldessarini RJ; Amici L; Innis RB; Tamagnan GD
Bioorg Med Chem Lett; 2003 Nov; 13(22):4015-7. PubMed ID: 14592497
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.
Moins N; Papon J; Seguin H; Gardette D; Moreau MF; Labarre P; Bayle M; Michelot J; Gramain JC; Madelmont JC; Veyre A
Nucl Med Biol; 2001 Oct; 28(7):799-808. PubMed ID: 11578901
[TBL] [Abstract][Full Text] [Related]
8. Detection of melanoma lesions using ¹³¹I-IMBA obtained by electrophilic substitution of ¹³¹I for metal organic substituent - a preliminary communication.
Janczak M; Nejc D; Bieńkiewicz M; Płachcińska A; Kuśmierek J
Nucl Med Rev Cent East Eur; 2010; 13(2):70-5. PubMed ID: 21598230
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated N-(alkylaminoalkyl)-substituted 4-methoxy-, 4-hydroxy-, and 4-aminobenzamides: biological investigations for the improvement of melanoma-imaging agents.
Mohammed A; Nicholl C; Titsch U; Eisenhut M
Nucl Med Biol; 1997 Jul; 24(5):373-80. PubMed ID: 9290070
[TBL] [Abstract][Full Text] [Related]
10. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a radioiodinated BODIPY derivative as a thiol-labeling agent.
Watanabe H; Itagaki F; Shimizu Y; Iikuni S; Ono M
J Labelled Comp Radiopharm; 2019 Nov; 62(13):885-891. PubMed ID: 31677180
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, radiosynthesis, and in vitro evaluation of [131I]-5-iodo-N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-yl)-ethyl]-2-methoxy-benzamide as a potential tumor imaging agent.
Xu YP; Yang M; Pan DH
Appl Radiat Isot; 2009 Apr; 67(4):594-7. PubMed ID: 19181532
[TBL] [Abstract][Full Text] [Related]
13. Development of 3-iodophenylisothiocyanate for radioiodination of monoclonal antibodies.
Ram S; Buchsbaum DJ
Int J Rad Appl Instrum A; 1992 Nov; 43(11):1387-91. PubMed ID: 1333460
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging.
Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
Bioorg Med Chem Lett; 2012 Aug; 22(16):5288-92. PubMed ID: 22796183
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides.
Efange SM; Michelson RH; Knusel B; Hefti F; Boudreau RJ; Thomas JR; Tennison JR
Nucl Med Biol; 1993 May; 20(4):527-38. PubMed ID: 8504292
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner R; Wester HJ; Reuning U; Senekowitsch-Schmidtke R; Diefenbach B; Kessler H; Stöcklin G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):1061-71. PubMed ID: 10452325
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
Moreau MF; Michelot J; Papon J; Bayle M; Labarre P; Madelmont JC; Parry D; Boire JY; Moins N; Seguin H
Nucl Med Biol; 1995 Aug; 22(6):737-47. PubMed ID: 8535334
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of [¹¹C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver.
Jahan M; Johnström P; Nag S; Takano A; Korsgren O; Johansson L; Halldin C; Eriksson O
Nucl Med Biol; 2015 Apr; 42(4):387-94. PubMed ID: 25633247
[TBL] [Abstract][Full Text] [Related]
20. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
Vaidyanathan G; Zalutsky MR
Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
